Early diagnosis and intervention can change the trajectory of FH1

Identification of FH at an early stage helps optimize patient care.1
Delve deeper into FH to​ support early diagnosis.

Making sense of homozygous FH guidelines

Dr Jaime Burkle, MD, FACC, cardiologist and FH expert, talks to Akima Harrigan, Associate Director for Field Medical Affairs at Regeneron, about the barriers to diagnosing HoFH and how he navigates this challenge.

Guidelines and recommendations​

Further reading for more information on pediatric lipid screening and FH diagnosis.

The National Heart, Lung and Blood Institute: Guidelines for cardiovascular health and risk reduction in children and adolescents

Early intervention and appropriate intervention can change the trajectory of FH.2

Visit resource

The American Heart Association: The agenda for familial hypercholesterolemia

Recommendations for heterozygous FH and homozygous FH diagnosis.3

Visit resource

The organizations listed are independent non-profit organizations.
Their inclusion here does not imply endorsement by Regeneron nor does it imply their endorsement of Regeneron or this resource center.

Discover more

Help us improve our content for you

​Take this 2-minute survey to let us know what you​
enjoyed about our website and what you would like to see in the future.​

Your valuable input will help us tailor our content to better suit your needs.

Take the survey

References

  1. McGowan MP et al. J Am Heart Assoc 2019;8:e013225.

  2. Nordestgaard et al. Eur Heart J 2013;34:3478-90a.

  3. Gidding SS et al. Circulation 2015;132:2167–2192.​